Galectin Therapeutics
Presença
Galectin Therapeutics é uma empresa listada sob o símbolo GALT (US).
Executivos
Veja o organograma con seus 20 executivos principais
Biografias mais buscadas da Galectin Therapeutics
- Joel Lewis, President, Chief Executive Officer and Director
- Kary Eldred, Director
- Richard Uihlein, Chairman of the Board
Recentes movimentos de executivos em Galectin Therapeutics
- Khurram Jamil, ingressou na Companhia como Vice President, Clinical Development (Notícia publicada em 13 de março de 2024).
- Benjamin Carson, ingressou na Companhia como Director (Notícia publicada em 12 de outubro de 2023).
Criar um alerta
para seguir os movimentos de executivos da Galectin Therapeutics.
Biotecnologia
Galectin Therapeutics possui 2.281 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Endeavor BioMedicines acaba de anunciar uma arrecadação de fundos de 132 milhões de dólares. (publicado em 25 de abril de 2024).
- Metsera acaba de anunciar uma arrecadação de fundos de 290 milhões de dólares. (publicado em 23 de abril de 2024).
- Histogen has filed for bankruptcy protection (publicado em 19 de abril de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Galectin Therapeutics
- Galectin Therapeutics Announces $60 Million Credit Line from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through 2024 | Galectin Therapeutics Inc.
- Galectin Therapeutics Announces 2 Liver Cirrhosis Scientific Presentations at the EASL International Liver Congress™ 2022 | Galectin Therapeutics Inc.
- Galectin Therapeutics to Present in Upcoming H.C. Wainwright Global Investment Conference and the 5th Global NASH Congress | Galectin Therapeutics Inc.
- Galectin Therapeutics Investor Conference Call and Webinar Taking Place Today | Galectin Therapeutics Inc.
- Galectin Therapeutics Announces Investor Conference Call and Webinar on September 29, 2020 | Galectin Therapeutics Inc.
- Galectin Therapeutics Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020 | Galectin Therapeutics Inc.
- Galectin Therapeutics Appoints Joel Lewis as Chief Executive Officer | Galectin Therapeutics Inc.
- Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2020, and Provides Business Update | Galectin Therapeutics Inc.
- Galectin Therapeutics Announces Commencement of Patient Enrollment of the Adaptively-Designed Phase 2b/3 Trial of Belapectin in NASH Cirrhosis | Galectin Therapeutics Inc.
- UPDATE -- Galectin Therapeutics Announces Commencement of Patient Enrollment of the Adaptively-Designed Phase 2b/3 Trial of Belapectin in NASH Cirrhosis | Galectin Therapeutics Inc.
- View more press releases Close
Redes sociais sobre Galectin Therapeutics
- Galectin Therapeutics na Wikipedia, Google News e Yahoo Finance
- Galectin Therapeutics na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Gilbert Amelio 
Ligue para a Galectin Therapeutics em +1 678...
